Shanghai GoBroad Cancer Hospital China Pharmaccutical University
Shanghai GoBroad Cancer Hospital China Pharmaccutical University
Shanghai, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. | KRAS G12D Mutations; Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting | Phase 2 | 2025-12-24 | NCT07303465 |